Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Cancers|October 24, 2020
Cutting the Brakes on Ras-Cytoplasmic GAPs as Targets of Inactivation in CancerArianna Bellazzo, Licio CollavinFrontiers in Genetics|April 6, 2023
Wild-type and mutant p53 in cancer-related ferroptosis. A matter of stress management?Marco Corazzari, Licio CollavinDevelopment (Cambridge, England)|December 31, 2002
The secreted Frizzled-related protein Sizzled functions as a negative feedback regulator of extreme ventral mesodermLicio Collavin, Marc W KirschnerCell Death and Differentiation|November 19, 2016
Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancerArianna Bellazzo, Giulio Di Minin, Licio CollavinCell Death and Differentiation|December 13, 2018
Mutant p53 as a guardian of the cancer cellFiamma Mantovani, Licio Collavin, Giannino Del SalCurrent Pharmaceutical Design|March 12, 2011
p73 as a pharmaceutical target for cancer therapyAndrea Bisso, Licio Collavin, Giannino Del SalMolecular & Cellular Oncology|June 17, 2016
Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancerArianna Bellazzo, Giulio Di Minin, Licio CollavinCell Death and Differentiation|June 20, 2024
An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implicationsRossella De Florian Fania, Arianna Bellazzo, Licio CollavinCell Cycle (Georgetown, Tex.)|July 16, 2004
KeePin' the p53 family in good shapeFiamma Mantovani, Monica Gostissa, Licio Collavin, et al.Carcinogenesis|July 24, 2012
The rebel angel: mutant p53 as the driving oncogene in breast cancerDawid Walerych, Marco Napoli, Licio Collavin, et al.Pageof 4